Related Experiment Video

Updated: Aug 13, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations

Maximilian Burger1, Stefan Denzinger, Christine Hammerschmied

  • 1Department of Urology, University of Regensburg, Germany.

European Urology
|January 18, 2006
PubMed
Abstract

Insights

Common B-RAF mutations are not found in prostate cancer. However, mitogen-activated protein kinase (MAPK) signaling is frequently active, suggesting it may be a therapeutic target for prostate tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Dysregulated mitogen-activated protein kinase (MAPK) pathway is implicated in various cancers.
  • B-RAF mutations are common in melanoma, thyroid, and colorectal cancers.
  • Prostate cancer pathogenesis and MAPK signaling require further investigation.

Purpose of the Study:

  • To investigate B-RAF mutations, microsatellite instability (MSI) status, and MAPK signaling activation in prostate tumors.
  • To determine the role of common B-RAF alterations in prostate carcinogenesis.
  • To explore potential therapeutic targets within the MAPK pathway for prostate cancer.

Main Methods:

  • Analysis of B-RAF V600E mutation and exons 11/15 sequencing in 79 prostate adenocarcinomas.
  • Determination of MSI status using the National Cancer Institute consensus panel.
  • Immunohistochemical assessment of active MAPK signaling (p44/ERK1, p42/ERK2).

Main Results:

  • No B-RAF mutations were detected in the studied prostate tumors.
  • Microsatellite instability (MSI) was observed in 6 out of 79 tumors.
  • Active MAPK signaling was present in 51% of prostate tumors, with no correlation to clinical characteristics.

Conclusions:

  • Frequent B-RAF alterations are not associated with prostate cancer development.
  • Microsatellite instability (MSI) is uncommon in prostate cancer and not linked to B-RAF mutations.
  • Frequent activation of MAPK signaling in prostate tumors suggests its potential as a therapeutic target.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...